HRTX Heron Therapeutics, Inc.
Healthcare$0.86-1.42%ClosedMarket Cap: $135.6M
As of 2026-05-25
Insider Statistics (Q2 2026)
Acquisitions
12
Dispositions
12
Buy/Sell Ratio
1.00
Net Shares
+0
Shares Acquired
354,318
Shares Disposed
354,318
Total Bought ($)
$0.00
Total Sold ($)
$0.00
Recent Insider Trades
| Filing Date | Name | Type | Action | Shares | Price | Shares After |
|---|---|---|---|---|---|---|
| Thu May 07 | Hensley Mark Earl | officer: Chief Operating Officer | Sell | 125,000 | $0.00 | 375,000 |
| Mon May 04 | Hensley Mark Earl | officer: Chief Operating Officer | Sell | 11,770 | $0.00 | 176,545 |
| Mon May 04 | Forbes William P | officer: EVP, Chief Development Officer | Sell | 11,770 | $0.00 | 209,111 |
| Mon May 04 | Forbes William P | officer: EVP, Chief Development Officer | Sell | 11,694 | $0.00 | 197,341 |
| Mon May 04 | Duarte Ira | officer: EVP, Chief Financial Officer | Sell | 13,535 | $0.00 | 252,128 |
| Mon May 04 | Duarte Ira | officer: EVP, Chief Financial Officer | Sell | 11,694 | $0.00 | 227,570 |
| Tue Apr 21 | Forbes William P | officer: EVP, Chief Development Officer | Sell | 3,874 | $0.00 | 185,647 |
| Tue Apr 21 | Duarte Ira | officer: EVP, Chief Financial Officer | Sell | 3,874 | $0.00 | 215,876 |
| Tue Apr 21 | Collard Craig A | director, officer: Chief Executive Officer | Sell | 13,797 | $0.00 | 662,052 |
| Mon Apr 06 | Collard Craig A | director, officer: Chief Executive Officer | Sell | 62,500 | $0.00 | 648,255 |
| Tue Feb 03 | Kaseta Michael | director | Sell | 53,960 | $0.00 | 53,960 |
| Tue Feb 03 | Johnson Craig A | director | Sell | 53,960 | $0.00 | 53,960 |
| Tue Feb 03 | Forbes William P | officer: EVP, Chief Development Officer | Sell | 188,315 | $0.00 | 188,315 |
| Tue Feb 03 | Forbes William P | officer: EVP, Chief Development Officer | Sell | 188,314 | $0.00 | 188,314 |
| Tue Feb 03 | Duarte Ira | officer: EVP, Chief Financial Officer | Sell | 216,562 | $0.00 | 216,562 |